Marcel van den Brink, MD, PhD

For years, clues pointed to the gut microbiome as a key factor in cancer treatment outcomes. Recent advances in gene sequencing are now clarifying its influence on how patients respond to therapy.

I am pleased to begin a new series from City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S. With our National Medical Center ranking among the top 5 for cancer by U.S. News & World Report, we are making a profound and lifesaving difference.